Executive officer

Ralf Kuriyel

Senior Vice President, Research and Development·Repligen Corp.

About

Ralf Kuriyel joined Repligen in October 2016 as the Senior Vice President, R&D where he oversees the Company's R&D efforts.

Mr. Kuriyel was previously Vice President of Applications for the single-use business unit within the Life Sciences division of Pall Corporation, whose acquisition by Danaher Corporation was completed in August 2015. At Pall, Mr. Kuriyel served as Vice President of R&D, Field Applications and Process Development Services from November 2014 to October 2016, and as Vice President, Applications R&D at Pall from November 2011 to November 2014.

Mr. Kuriyel received a B.S. and an M.S. in Chemical Engineering from Rensselaer Polytechnic Institute and has completed his coursework for the Tufts University Ph.D. program in Chemical Engineering. He is an inventor of multiple patents and has co-authored over 30 scientific publications on bioprocessing.

Since 2016
Age 67
Tenure 10 yrs

Also at Repligen Corp.

OL Olivier Loeillot President and Chief Executive Officer, Director MM Martin D. Madaus Director, Chair of the Board KD Karen A. Dawes Director NB Nicolas M. Barthelemy Director CM Carrie Eglinton Manner Director KK Konstantin Konstantinov Director

Roles

Organization Role Dates Details
Repligen Corp. Senior Vice President, Research and Development 2016–present Current role
Pall Corporation Vice President of R&D, Field Applications and Process Development Services 2014-2016 Single-use business unit within Life Sciences division; Pall's acquisition by Danaher Corporation completed August 2015. November 2014 to October 2016.
Pall Corporation Vice President, Applications R&D 2011-2014 November 2011 to November 2014.

Related

Company Repligen Corp. Company hub Person Olivier Loeillot President and Chief Executive Officer, Director Person Martin D. Madaus Director, Chair of the Board Person Karen A. Dawes Director Person Nicolas M. Barthelemy Director Person Carrie Eglinton Manner Director Person Konstantin Konstantinov Director Person Rohin Mhatre Director Person Glenn P. Muir Director Person Margaret A. Pax Director Person Jason K. Garland Chief Financial Officer Person James Bylund Chief Operating Officer Person Brian Douglass Senior Vice President, Chief Product Officer Deal Repligen Artesyn Biosolutions Ireland Limited 2020 Deal page Deal Repligen Atoll Gmbh 2016 Deal page Deal Repligen Avitide 2021 Deal page
Source: Repligen Corp. proxy statement (SEC Schedule 14A)

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo